ANDA Litigation Settlements

Winter 2015

Robins Kaplan GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Case Name Drug Patent No(s). Publicly Available Terms

Helsinn Healthcare SA v. Dr. Reddy’s Labs. Ltd., 11-3962 (D.N.J.)

Aloxi®(palonosetron hydrochloride for injection)




Dr. Reddy’s will be allowed to market generic Aloxi on Sept. 30, 2018, or earlier under undisclosed circumstances.

Remaining terms are confidential.

Back to Top